Addus HomeCare Co. (NASDAQ:ADUS) Receives Average Rating of “Buy” from Analysts

Addus HomeCare Co. (NASDAQ:ADUS) has earned an average rating of “Buy” from the ten ratings firms that are currently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, seven have assigned a buy recommendation and two have assigned a strong buy recommendation to the company. The average 1-year target price among brokers that have updated their coverage on the stock in the last year is $132.78.

Several equities analysts have issued reports on ADUS shares. Stephens reaffirmed an “overweight” rating and set a $142.00 price objective on shares of Addus HomeCare in a report on Wednesday, March 12th. Macquarie reissued an “outperform” rating and issued a $129.00 price objective on shares of Addus HomeCare in a report on Thursday, February 27th. JMP Securities reiterated a “market outperform” rating and issued a $150.00 price target on shares of Addus HomeCare in a research report on Thursday, April 10th. StockNews.com lowered shares of Addus HomeCare from a “buy” rating to a “hold” rating in a research note on Wednesday, February 26th. Finally, Oppenheimer raised their price target on Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a report on Friday, January 24th.

Addus HomeCare Price Performance

Shares of NASDAQ ADUS opened at $99.24 on Friday. The business has a 50-day moving average of $100.32 and a two-hundred day moving average of $117.64. The company has a market capitalization of $1.80 billion, a price-to-earnings ratio of 22.71, a price-to-earnings-growth ratio of 1.41 and a beta of 0.93. Addus HomeCare has a 1 year low of $87.88 and a 1 year high of $136.72.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings results on Monday, February 24th. The company reported $1.26 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.35 by ($0.09). The business had revenue of $297.14 million during the quarter, compared to analyst estimates of $291.04 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. As a group, equities research analysts expect that Addus HomeCare will post 4.59 earnings per share for the current year.

Institutional Investors Weigh In On Addus HomeCare

A number of hedge funds and other institutional investors have recently bought and sold shares of ADUS. Capital Research Global Investors purchased a new stake in shares of Addus HomeCare during the 4th quarter worth approximately $51,149,000. American Century Companies Inc. boosted its holdings in shares of Addus HomeCare by 695.8% during the fourth quarter. American Century Companies Inc. now owns 284,346 shares of the company’s stock worth $35,643,000 after purchasing an additional 248,613 shares during the last quarter. GAMMA Investing LLC grew its holdings in Addus HomeCare by 10,307.8% in the 1st quarter. GAMMA Investing LLC now owns 130,930 shares of the company’s stock valued at $12,948,000 after buying an additional 129,672 shares during the period. Bank of America Corp DE grew its holdings in Addus HomeCare by 273.6% in the fourth quarter. Bank of America Corp DE now owns 175,070 shares of the company’s stock valued at $21,945,000 after purchasing an additional 128,211 shares during the period. Finally, TimesSquare Capital Management LLC grew its stake in shares of Addus HomeCare by 28.5% during the 4th quarter. TimesSquare Capital Management LLC now owns 355,750 shares of the company’s stock valued at $44,593,000 after buying an additional 78,835 shares during the period. Institutional investors and hedge funds own 95.35% of the company’s stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.